Celularity (CELUW) Accounts Payables (2018 - 2025)
Celularity (CELUW) reported Accounts Payables of $26.4 million for Q4 2025, up 13.42% year-over-year from $23.3 million in Q4 2024, and up 7.46% quarter-over-quarter from $24.6 million in Q3 2025.
Celularity (CELUW) Accounts Payables (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 8 years of Accounts Payables data on file, last reported at $26.4 million in Q4 2025.
- Accounts Payables for Q4 2025 came in at $26.4 million, up 13.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $26.4 million (up 13.42% YoY), and the FY2025 annual result was $26.4 million, up 13.42% from the prior year.
- Accounts Payables advanced to $26.4 million in Q4 2025 per CELUW's latest filing, from $24.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $26.4 million in Q4 2025 and troughed at $5.0 million in Q1 2021.
- A 5-year average of $13.8 million and a median of $12.7 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2021 and 2022: Accounts Payables soared 12694.08% in 2021, then slumped 37.64% in 2022.
- A 5-year view of Accounts Payables shows it stood at $9.3 million in 2021, then plunged by 37.64% to $5.8 million in 2022, then surged by 143.44% to $14.1 million in 2023, then jumped by 64.71% to $23.3 million in 2024, then gained by 13.42% to $26.4 million in 2025.
- Business Quant data shows CELUW's Accounts Payables at $26.4 million in Q4 2025, $24.6 million in Q3 2025, and $24.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 26.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.42 Mn |
| Sep 30, 2025 | 24.59 Mn |
| Jun 30, 2025 | 24.40 Mn |
| Mar 31, 2025 | 23.31 Mn |
| Dec 31, 2024 | 23.30 Mn |
| Sep 30, 2024 | 15.40 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 14.14 Mn |
| Sep 30, 2023 | 12.93 Mn |
| Jun 30, 2023 | 12.45 Mn |
| Mar 31, 2023 | 8.76 Mn |
| Dec 31, 2022 | 5.81 Mn |
| Sep 30, 2022 | 9.22 Mn |
| Jun 30, 2022 | 10.23 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Dec 31, 2021 | 9.32 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 6.18 Mn |
| Mar 31, 2021 | 5.04 Mn |